Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Exposure-based Treatment for Avoidant Back Pain Patients (ETABP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01484418
Recruitment Status : Completed
First Posted : December 2, 2011
Last Update Posted : September 5, 2017
Sponsor:
Collaborators:
Psychotherapie-Ambulanz Marburg e.V.
German Research Foundation
Information provided by (Responsible Party):
Julia Anna Glombiewski, Philipps University Marburg Medical Center

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
Chronic low back pain often results in psychosocial and physical disability. A subgroup of these patients shows fear of (re)injury and avoidance behaviour leading to higher disability. The purpose of this study is to determine whether exposure in vivo is more effective in the treatment of fear avoidant chronic back pain patients than psychological treatment as usual (cognitive behavioural psychotherapy).

Condition or disease Intervention/treatment Phase
Low Back Pain Behavioral: Exposure in vivo Behavioral: Cognitive Behavioural Psychotherapy Not Applicable

Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 68 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Exposure Therapy in Chronic Low Back Pain Patients
Study Start Date : August 2011
Actual Primary Completion Date : August 2015
Actual Study Completion Date : August 2017

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Back Pain

Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: A Exposure long
Exposure in vivo for fear avoidant chronic low back pain patients. This treatment means that the individual is exposed to movements and tasks that have been avoided due to fear of (re)injury. The treatment begins after three educational lessons including the rational and developing a fear hierarchy. Exposure phase includes 10 exposures sessions which are highly individualized. Behavioral experiments can be included to correct catastrophic misinterpretations. The main purpose of this intervention type is to reduce pain related disability via diminishing fear avoidance.
 Behavioral: Exposure in vivo
5-10 sessions based on an individualized fear hierarchy
Experimental: B Exposure short
See above exposure long. This treatment comprises 5 exposure sessions.
 Behavioral: Exposure in vivo
5-10 sessions based on an individualized fear hierarchy
Active Comparator: C Cognitive behavioural psychotherapy
Cognitive behavioural psychotherapy for fear avoidant chronic low back patients. The therapy is modularized in three main parts. The educational lesson is followed by the module graded activity which represents the behavioral part of the program. The second module comprises relaxation. And the last part contains cognitive interventions. Cognitive behavioural intervention techniques are employed to support the patient in the process of coping with chronic pain: i.e. reduction of disability and improving functional ability.
 Behavioral: Cognitive Behavioural Psychotherapy
graded activity, relaxation techniques and cognitive interventions


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Change from baseline in pain severity at 3 and 6 months after admission [ Time Frame: from Pretest (admission) to Posttest (an expected average of 3 months after admission) to Follow-up (an expected average of 6 months after admission) ]
    Numeric Rating Scale (NRS)

  2. Change from baseline in pain disability at 3 and 6 months after admission [ Time Frame: from Pretest (admission) to Posttest (an expected average of 3 months after admission) to Follow-up (an expected average of 6 months after admission) ]
    Pain Disability Index (PDI) Quebec Back Pain Disability Scale (QBPDS)


Secondary Outcome Measures :
  1. Change in fear avoidance from Pretest to two in-between time points to Posttest [ Time Frame: from Pretest (admission) to one in-between timepoint (an expected 10 weeks after admission) to Posttest (an expected average of 3 months after admission) to Follow-up (an expected average of 6 months after admission) ]
    Tampa Scale of Kinesiophobia (TSK) Pain Anxiety Symptom Scale (PASS)

  2. Change in pain catastrophizing from Pretest to two in-between timepoints to Posttest to Follow-up [ Time Frame: from Pretest (admission) to one in-between timepoint (an expected 10 weeks after admission) to Posttest (an expected average of 3 months after admission) to Follow-up (an expected average of 6 months after admission) ]
    Pain Catastrophizing Scale (PCS)

  3. Change in emotional distress from Pretest to two in-between timepoints to Posttest to Follow-up [ Time Frame: from Pretest (admission) to one in-between timepoint (an expected 10 weeks after admission) to Posttest (an expected average of 3 months after admission) to Follow-up (an expected average of 6 months after admission) ]
    Hospital Anxiety and Depression Scale (HADS)

  4. Change in quality of life from Pretest to two in-between timepoints to Posttest to Follow-up [ Time Frame: from Pretest (admission) to one in-between timepoint (an expected 10 weeks after admission) to Posttest (an expected average of 3 months after admission) to Follow-up (an expected average of 6 months after admission) ]
    EuroQol (EQ-5D)

  5. Change in physical activity from Pretest to two in-between timepoints to Posttest to Follow-up Time [ Time Frame: from Pretest (admission) to one in-between timepoint (an expected 10 weeks after admission) to Posttest (an expected average of 3 months after admission) to Follow-up (an expected average of 6 months after admission) ]
    International Physical Activity Questionnaire(IPAQ)


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Having at least 3 months back pain
  • Sufficient level on fear avoidance scores (TSK, Phoda)
  • Being German-speaking
  • Agreeing to participate, verified by completion of informed consent

Exclusion Criteria:

  • Red flags
  • Pregnancy
  • Illiteracy
  • Psychoses
  • Alcohol addiction
  • surgeries during the last 6 months or planed surgeries
  • Specific medical disorders or cardiovascular diseases preventing participation in physical exercise
  • Participating in another psychotherapy
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01484418


Locations
Layout table for location information
Germany
Philipps University Marburg, Department of Clinical Psychology and Psychotherapy
Marburg, Germany, 35037
Sponsors and Collaborators
Philipps University Marburg Medical Center
Psychotherapie-Ambulanz Marburg e.V.
German Research Foundation
Investigators
Layout table for investigator information
Study Director: Winfried Rief, Prof. Philipps University Marburg, Department of Clinical Psychology and Psychotherapy
Study Chair: Julia A. Glombiewski, Dr. Philipps University Marburg, Department of Clinical Psychology and Psychotherapy
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Layout table for additonal information
Responsible Party: Julia Anna Glombiewski, Ph.D, Licensed Psychologist, Principal Investigator, Philipps University Marburg Medical Center
ClinicalTrials.gov Identifier: NCT01484418    
Other Study ID Numbers: DFG-GL 607
First Posted: December 2, 2011    Key Record Dates
Last Update Posted: September 5, 2017
Last Verified: September 2017
Keywords provided by Julia Anna Glombiewski, Philipps University Marburg Medical Center:
Chronic Low Back Pain
Cognitive Behavioural Therapy
Exposure
 Fear avoidance
Cognitive Behavioural Therapy in chronic low back pain
Exposure in vivo in chronic low back pain
Additional relevant MeSH terms:
Layout table for MeSH terms
Back Pain
Low Back Pain
Pain
Neurologic Manifestations